OraSure Technologies Inc. and partner Roche said Thursday the Food and Drug Administration cleared the companies' drug tests for use with the Intercept drug testing system.
The approved oral tests seek to find traces of abuse for drugs including cocaine, opiates and methamphetamine. OraSure makes the Intercept system.
"We are very pleased to announce this significant milestone in our joint effort with Roche to develop and market these important drugs of abuse (tests) assays," said OraSure President and CEO Douglas A. Michels, in a statement.
OraSure, based in Bethlehem, Pa., makes diagnostic kits to detect HIV and drug use.